Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary tumor cells.

Tulipano G, Giustina A.

Pituitary. 2020 Jan 29. doi: 10.1007/s11102-020-01028-0. [Epub ahead of print]

PMID:
31997055
2.

How treatments with endocrine and metabolic drugs influence pituitary cell function.

Tulipano G.

Endocr Connect. 2020 Feb;9(2):R14-R27. doi: 10.1530/EC-19-0482. Review.

3.

International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S.

Pharmacol Rev. 2018 Oct;70(4):763-835. doi: 10.1124/pr.117.015388. Review.

4.

Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.

Faggi L, Giustina A, Tulipano G.

Mol Cell Endocrinol. 2018 Jul 15;470:60-74. doi: 10.1016/j.mce.2017.09.030. Epub 2017 Sep 27.

PMID:
28962892
5.

Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells.

Tulipano G, Faggi L, Schulz S, Spinello M, Giustina A.

Endocrine. 2017 Jul;57(1):179-182. doi: 10.1007/s12020-017-1235-3. Epub 2017 Jan 24. No abstract available.

PMID:
28120181
6.

MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.

Faggi F, Codenotti S, Poliani PL, Cominelli M, Chiarelli N, Colombi M, Vezzoli M, Monti E, Bono F, Tulipano G, Fiorentini C, Zanola A, Lo HP, Parton RG, Keller C, Fanzani A.

PLoS One. 2015 Jun 18;10(6):e0130287. doi: 10.1371/journal.pone.0130287. eCollection 2015.

7.
8.

Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.

Tulipano G, Faggi L, Cacciamali A, Spinello M, Cocchi D, Giustina A.

Pituitary. 2014 Jun;17(3):203-9. doi: 10.1007/s11102-013-0488-y.

PMID:
23649927
9.

Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells.

Tulipano G, Faggi L, Losa M, Mortini P, Spinello M, Sibilia V, Pagani F, Cocchi D, Giustina A.

Mol Cell Endocrinol. 2013 Jan 30;365(2):197-206. doi: 10.1016/j.mce.2012.10.017. Epub 2012 Oct 29.

PMID:
23116772
10.

Points of integration between the intracellular energy sensor AMP-activated protein kinase (AMPK) activity and the somatotroph axis function.

Tulipano G, Faggi L, Sibilia V, Giustina A.

Endocrine. 2012 Oct;42(2):292-8. Epub 2012 Jun 27. Review.

PMID:
22736409
11.

Pharmacological characterization of the ghrelin receptor mediating its inhibitory action on inflammatory pain in rats.

Sibilia V, Pagani F, Mrak E, Dieci E, Tulipano G, Ferrucci F.

Amino Acids. 2012 Oct;43(4):1751-9. Epub 2012 Mar 10.

12.

Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors.

Tulipano G, Sibilia V, Caroli AM, Cocchi D.

Peptides. 2011 Apr;32(4):835-8. doi: 10.1016/j.peptides.2011.01.002. Epub 2011 Jan 20.

PMID:
21256171
13.

AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cells.

Tulipano G, Giovannini M, Spinello M, Sibilia V, Giustina A, Cocchi D.

Pituitary. 2011 Sep;14(3):242-52. doi: 10.1007/s11102-010-0288-6.

PMID:
21213053
14.

Characterization of the mechanisms involved in the gastric antisecretory effect of TLQP-21, a vgf-derived peptide, in rats.

Sibilia V, Pagani F, Bulgarelli I, Tulipano G, Possenti R, Guidobono F.

Amino Acids. 2012 Apr;42(4):1261-8. doi: 10.1007/s00726-010-0818-6. Epub 2010 Dec 4.

PMID:
21132337
15.

Impact of integrated pest management (IPM) training on reducing pesticide exposure in Illinois childcare centers.

Mir DF, Finkelstein Y, Tulipano GD.

Neurotoxicology. 2010 Sep;31(5):621-6. doi: 10.1016/j.neuro.2010.05.013. Epub 2010 Jun 17. Erratum in: Neurotoxicology. 2010 Dec;31(6):765.

PMID:
20600293
16.

Direct effects of casein phosphopeptides on growth and differentiation of in vitro cultured osteoblastic cells (MC3T3-E1).

Tulipano G, Bulgari O, Chessa S, Nardone A, Cocchi D, Caroli A.

Regul Pept. 2010 Feb 25;160(1-3):168-74. doi: 10.1016/j.regpep.2009.11.018. Epub 2009 Dec 4.

PMID:
19963015
17.

Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat: Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring.

Cocchi D, Tulipano G, Colciago A, Sibilia V, Pagani F, Viganò D, Rubino T, Parolaro D, Bonfanti P, Colombo A, Celotti F.

Toxicol Appl Pharmacol. 2009 Jun 1;237(2):127-36. doi: 10.1016/j.taap.2009.03.008. Epub 2009 Mar 24.

PMID:
19327374
18.

Effects of olanzapine on glucose transport, proliferation and survival in C2C12 myoblasts.

Tulipano G, Spano P, Cocchi D.

Mol Cell Endocrinol. 2008 Sep 24;292(1-2):42-9. doi: 10.1016/j.mce.2008.04.010. Epub 2008 Apr 25.

PMID:
18514390
19.

Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125.

Tulipano G, Taylor JE, Halem HA, Datta R, Dong JZ, Culler MD, Bianchi I, Cocchi D, Giustina A.

Pituitary. 2007;10(3):267-74.

PMID:
17587180
20.

Novel insights in somatostatin receptor physiology.

Tulipano G, Schulz S.

Eur J Endocrinol. 2007 Apr;156 Suppl 1:S3-11. Review. Erratum in: Eur J Endocrinol. 2007 Oct;157(4):543.

PMID:
17413186
21.

Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation.

Tulipano G, Rizzetti C, Bianchi I, Fanzani A, Spano P, Cocchi D.

Neuroendocrinology. 2007;85(2):61-70. Epub 2007 Mar 19.

PMID:
17374945
22.

GH-releasing peptides and bone.

Cocchi D, Maccarinelli G, Sibilia V, Tulipano G, Torsello A, Pazzaglia UE, Giustina A, Netti C.

J Endocrinol Invest. 2005;28(8 Suppl):11-4. Review.

PMID:
16323823
23.

Somatostatin receptor 2 is activated in cortical neurons and contributes to neurodegeneration after focal ischemia.

Stumm RK, Zhou C, Schulz S, Endres M, Kronenberg G, Allen JP, Tulipano G, Höllt V.

J Neurosci. 2004 Dec 15;24(50):11404-15.

24.

The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.

Tulipano G, Rossi E, Culler MD, Taylor JE, Bonadonna S, Locatelli V, Cocchi D, Giustina A.

Regul Pept. 2005 Feb 15;125(1-3):85-92.

PMID:
15582718
25.
26.

Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: In vitro studies.

Tulipano G, Bonfanti C, Poiesi C, Burattin A, Turazzi S, Barone G, Cozzi R, Bollati A, Valle D, Giustina A.

Metabolism. 2004 May;53(5):563-70.

PMID:
15131758
27.

Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.

Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Höllt V, Schulz S.

J Biol Chem. 2004 May 14;279(20):21374-82. Epub 2004 Mar 4.

28.

Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships?

De Menis E, Tulipano G, Villa S, Billeci D, Bonfanti C, Pollara P, Pauletto P, Giustina A.

J Endocrinol Invest. 2003 Apr;26(4):359-63.

PMID:
12841545
29.

Ghrelin plays a minor role in the physiological control of cardiac function in the rat.

Torsello A, Bresciani E, Rossoni G, Avallone R, Tulipano G, Cocchi D, Bulgarelli I, Deghenghi R, Berti F, Locatelli V.

Endocrinology. 2003 May;144(5):1787-92.

30.

Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting.

Bagnasco M, Tulipano G, Melis MR, Argiolas A, Cocchi D, Muller EE.

Regul Pept. 2003 Mar 28;111(1-3):161-7.

PMID:
12609764
32.

Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.

Tulipano G, Bonfanti C, Milani G, Billeci B, Bollati A, Cozzi R, Maira G, Murphy WA, Poiesi C, Turazzi S, Giustina A.

Neuroendocrinology. 2001 May;73(5):344-51.

PMID:
11399907
33.

Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.

Rusnati M, Taraboletti G, Urbinati C, Tulipano G, Giuliani R, Molinari-Tosatti MP, Sennino B, Giacca M, Tyagi M, Albini A, Noonan D, Giavazzi R, Presta M.

FASEB J. 2000 Oct;14(13):1917-30.

PMID:
11023976
34.

Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides.

Rusnati M, Tulipano G, Spillmann D, Tanghetti E, Oreste P, Zoppetti G, Giacca M, Presta M.

J Biol Chem. 1999 Oct 1;274(40):28198-205.

35.

Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.

Rusnati M, Tanghetti E, Urbinati C, Tulipano G, Marchesini S, Ziche M, Presta M.

Mol Biol Cell. 1999 Feb;10(2):313-27.

36.

The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.

Rusnati M, Tulipano G, Urbinati C, Tanghetti E, Giuliani R, Giacca M, Ciomei M, Corallini A, Presta M.

J Biol Chem. 1998 Jun 26;273(26):16027-37.

37.

Interferon rapidly induces modifications of chromatin sensitivity to DNase I in Daudi lymphoma cells.

Cataldi A, Lisio R, Rana R, Bareggi R, Tulipano G, Miscia S.

Exp Cell Res. 1993 Jan;204(1):167-9.

PMID:
7677985
38.

Interferon affects cell growth progression by modulating DNA polymerases activity.

Cataldi A, Santavenere E, Vitale M, Trubiani O, Lisio R, Tulipano G, Di Domenicantonio L, Zamai L, Miscia S.

Cell Prolif. 1992 May;25(3):225-31.

PMID:
1596535
39.

Interferon transiently modulates intranuclear signalling system in erythroleukemia Friend cells.

Miscia S, Cataldi A, Lisio R, Tulipano G, Rizzoli R, Rana R, Cocco L.

Cell Biol Int Rep. 1991 May;15(5):427-35.

PMID:
1655286

Supplemental Content

Loading ...
Support Center